Effect of dietary lipids on circulating adiponectin: A systematic review with meta-analysis of randomised controlled trials

British Journal of Nutrition

Volumn 112, Issue 8, 2014, Pages 1235-1250

  Von Frankenberg, Anize D ^a,b   Silva, Flávia M ^a   De Almeida, Jussara C ^a,b   Piccoli, Vanessa ^a   Do Nascimento, Filipe V ^a   Sost, Mônica M ^a   Leitão, Cristiane B ^a,b   Remonti, Luciana L R ^a,b   Umpierre, Daniel ^b   Reis, André F ^c   Canani, Luis H ^a,b   De Azevedo, Mirela J ^a,b   Gerchman, Fernando ^a,b  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^c FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Adiponectin; Conjugated linoleic acid; Dietary lipids; n 3 PUFA

Indexed keywords

ADIPONECTIN; CONJUGATED LINOLEIC ACID; OMEGA 3 FATTY ACID; ADIPOQ PROTEIN, HUMAN; FAT INTAKE;

CALORIC INTAKE; DIET SUPPLEMENTATION; ENERGY CONSUMPTION; FAT CONTENT; FAT INTAKE; FOLLOW UP; FOOD COMPOSITION; HUMAN; META ANALYSIS; NUTRIENT CONCENTRATION; NUTRIENT MANAGEMENT; NUTRITIONAL HEALTH; OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW; WEIGHT CHANGE; ADMINISTRATION AND DOSAGE; ADULT; ADVERSE EFFECTS; AGONISTS; BLOOD; COMPARATIVE STUDY; DOWN REGULATION; LIPID DIET; LOW FAT DIET; REPRODUCIBILITY; THERAPEUTIC USE; UPREGULATION;

SCOPUS;

ADIPONECTIN; ADULT; DIET, FAT-RESTRICTED; DIET, HIGH-FAT; DIETARY FATS; DIETARY SUPPLEMENTS; DOWN-REGULATION; FATTY ACIDS, OMEGA-3; HUMANS; LINOLEIC ACIDS, CONJUGATED; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REPRODUCIBILITY OF RESULTS; UP-REGULATION;

EID: 84922070055     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114514002013     Document Type: Review

References (77)

1. Ahima RS (2006) Metabolic actions of adipocyte hormones: focus on adiponectin. Obesity (Silver Spring) 14, Suppl. 1, 9S-15S.
2. Schulze MB, Shai I, Rimm EB, et al. (2005) Adiponectin and future coronary heart disease events among men with type 2 diabetes. Diabetes 54, 534-539.
3. von Frankenberg AD, do Nascimento FV, Gatelli LE, et al. (2014) Major components of metabolic syndrome and adiponectin levels: a cross-sectional study. Diabetol Metab Syndr 6, 26.
4. Rossmeislova L, Malisova L, Kracmerova J, et al. (2013) Weight loss improves the adipogenic capacity of human preadipocytes and modulates their secretory profile. Diabetes 62, 1990-1995.
5. Simpson KA & Singh MA (2008) Effects of exercise on adiponectin: a systematic review. Obesity (Silver Spring) 16, 241-256.
6. Mantzoros CS, Williams CJ, Manson JE, et al. (2006) Adherence to the Mediterranean dietary pattern is positively associated with plasma adiponectin concentrations in diabetic women. Am J Clin Nutr 84, 328-335.
7. Arvidsson E, Viguerie N, Andersson I, et al. (2004) Effects of different hypocaloric diets on protein secretion from adipose tissue of obese women. Diabetes 53, 1966-1971.
8. Keogh JB, Brinkworth GD, Noakes M, et al. (2008) Effects of weight loss from a very-low-carbohydrate diet on endothelial function and markers of cardiovascular disease risk in subjects with abdominal obesity. Am J Clin Nutr 87, 567-576.
9. Wycherley TP, Brinkworth GD, Keogh JB, et al. (2010) Longterm effects of weight loss with a very low carbohydrate and low fat diet on vascular function in overweight and obese patients. J Intern Med 267, 452-461.
10. Trichopoulou A, Costacou T, Bamia C, et al. (2003) Adherence to a Mediterranean diet and survival in a Greek population. N Engl J Med 348, 2599-2608.
11. Qi L, Rimm E, Liu S, et al. (2005) Dietary glycemic index, glycemic load, cereal fiber, and plasma adiponectin concentration in diabetic men. Diabetes Care 28, 1022-1028.
12. Silva FM, de Almeida JC & Feoli AM (2011) Effect of diet on adiponectin levels in blood. Nutr Rev 69, 599-612.
13. Wu JH, Cahill LE & Mozaffarian D (2013) Effect of fish oil on circulating adiponectin: a systematic review and metaanalysis of randomized controlled trials. J Clin Endocrinol Metab 98, 2451-2459.
14. The Cochrane Collaboration (2011) Cochrane Handbook for Systematic Reviews of Interventions, version 5.1.0. www.cochrane-handbook.org
15. Liberati A, Altman DG, Tetzlaff J, et al. (2009) The PRISMA statement for reporting systematic reviews and metaanalyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol 62, e1-34.
16. Blüher M, Rudich A, Kloting N, et al. (2012) Two patterns of adipokine and other biomarker dynamics in a long-term weight loss intervention. Diabetes Care 35, 342-349.
17. Shademan Z, Rastmanesh R & Hedayati M (2011) Effect of conjugated linoleic acid on serum leptin, adiponectin and body composition in overweight type II diabetic patients. Kowsar Med J 16, 101-107.
18. Brons C, Jensen CB, Storgaard H, et al. (2009) Impact of short-term high-fat feeding on glucose and insulin metabolism in young healthy men. J Physiol 587, 2387-2397.
19. Varady KA, Bhutani S, Klempel MC, et al. (2011) Improvements in vascular health by a low-fat diet, but not a highfat diet, are mediated by changes in adipocyte biology. Nutr J 10, 8.
20. Bendsen NT, Stender S, Szecsi PB, et al. (2011) Effect of industrially produced trans fat on markers of systemic inflammation: evidence from a randomized trial in women. J Lipid Res 52, 1821-1828.
21. Sofi F, Giangrandi I, Cesari F, et al. (2010) Effects of a 1-year dietary intervention with n-3 polyunsaturated fatty acidenriched olive oil on non-alcoholic fatty liver disease patients: a preliminary study. Int J Food Sci Nutr 61, 792-802.
22. Vargas ML, Almario RU, Buchan W, et al. (2011) Metabolic and endocrine effects of long-chain versus essential omega-3 polyunsaturated fatty acids in polycystic ovary syndrome. Metabolism 60, 1711-1718.
23. Taylor CG, Noto AD, Stringer DM, et al. (2010) Dietary milled flaxseed and flaxseed oil improve N-3 fatty acid status and do not affect glycemic control in individuals with well-controlled type 2 diabetes. J Am Coll Nutr 29, 72-80.
24. Troseid M, Arnesen H, Hjerkinn EM, et al. (2009) Serum levels of interleukin-18 are reduced by diet and n-3 fatty acid intervention in elderly high-risk men. Metabolism 58, 1543-1549.
25. Higgins JPT & Green S (2011) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [Updated March 2011]. http://www.cochrane-handbook.org (accessed 16 April 2014)
26. Follmann D, Elliott P, Suh I, et al. (1992) Variance imputation for overviews of clinical trials with continuous response. J Clin Epidemiol 45, 769-773.
27. Der Simonian R & Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7, 177-188.
28. Peters JL, Sutton AJ, Jones DR, et al. (2007) Performance of the trim and fill method in the presence of publication bias and between-study heterogeneity. Stat Med 26, 4544-4562.
29. Begg CB & Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50, 1088-1101.
30. Egger M, Davey Smith G, Schneider M, et al. (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315, 629-634.
31. Cardillo S, Seshadri P & Iqbal N (2006) The effects of a low-carbohydrate versus low-fat diet on adipocytokines in severely obese adults: three-year follow-up of a randomized trial. Eur Rev Med Pharmacol Sci 10, 99-106.
32. Ng TW, Watts GF, Barrett PH, et al. (2007) Effect of weight loss on LDL and HDL kinetics in the metabolic syndrome: associations with changes in plasma retinol-binding protein-4 and adiponectin levels. Diabetes Care 30, 2945-2950.
33. Keogh JB, Brinkworth GD & Clifton PM (2007) Effects of weight loss on a low-carbohydrate diet on flow-mediated dilatation, adhesion molecules and adiponectin. Br J Nutr 98, 852-859.
34. Al-Sarraj T, Saadi H, Calle MC, et al. (2009) Carbohydrate restriction, as a first-line dietary intervention, effectively reduces biomarkers of metabolic syndrome in Emirati adults. J Nutr 139, 1667-1676.
35. Vetter ML, Wade A, Womble LG, et al. (2010) Effect of a lowcarbohydrate diet versus a low-fat, calorie-restricted diet on adipokine levels in obese, diabetic participants. Diabetes Metab Syndr Obes 3, 357-361.
36. Yeung EH, Appel LJ, Miller ER, et al. (2010) The effects of macronutrient intake on total and high-molecular weight adiponectin: results from the OMNI-Heart trial. Obesity (Silver Spring) 18, 1632-1637.
37. Summer SS, Brehm BJ, Benoit SC, et al. (2011) Adiponectin changes in relation to the macronutrient composition of a weight-loss diet. Obesity 19, 2198-2204.
38. Heggen E, Klemsdal TO, Haugen F, et al. (2012) Effect of a low-fat versus a low-glycemic-load diet on inflammatory biomarker and adipokine concentrations. Metab Syndr Relat Disord 10, 437-442.
39. Rajaie S, Azadbakht L, Saneei P, et al. (2012) The effect of moderate substitution of dietary carbohydrates by fats on serum levels of adipocytokines, inflammatory indices, and biomarkers of endothelial function among women with metabolic syndrome. J Zanjan Univer Med Sci Health Services 20.
40. Krebs JD, Browning LM, McLean NK, et al. (2006) Additive benefits of long-chain n-3 polyunsaturated fatty acids and weight-loss in the management of cardiovascular disease risk in overweight hyperinsulinaemic women. Int J Obes (Lond) 30, 1535-1544.
41. Kabir M, Skurnik G, Naour N, et al. (2007) Treatment for 2mo with n 3 polyunsaturated fatty acids reduces adiposity and some atherogenic factors but does not improve insulin sensitivity in women with type 2 diabetes: a randomized controlled study. Am J Clin Nutr 86, 1670-1679.
42. Damsgaard CT, Frokiaer H, Andersen AD, et al. (2008) Fish oil in combination with high or low intakes of linoleic acid lowers plasma triacylglycerols but does not affect other cardiovascular risk markers in healthy men. J Nutr 138, 1061-1066.
43. Kratz M, Swarbrick MM, Callahan HS, et al. (2008) Effect of dietary n-3 polyunsaturated fatty acids on plasma total and high-molecular-weight adiponectin concentrations in overweight to moderately obese men and women. Am J Clin Nutr 87, 347-353.
44. Ramel A, Martinez A, Kiely M, et al. (2008) Beneficial effects of long-chain n-3 fatty acids included in an energy-restricted diet on insulin resistance in overweight and obese European young adults. Diabetologia 51, 1261-1268.
45. Sneddon AA, Tsofliou F, Fyfe CL, et al. (2008) Effect of a conjugated linoleic acid and omega-3 fatty acid mixture on body composition and adiponectin. Obesity (Silver Spring) 16, 1019-1024.
46. Micallef MA & Garg ML (2009) Anti-inflammatory and cardioprotective effects of n-3 polyunsaturated fatty acids and plant sterols in hyperlipidemic individuals. Atherosclerosis 204, 476-482.
47. Rizza S, Tesauro M, Cardillo C, et al. (2009) Fish oil supplementation improves endothelial function in normoglycemic offspring of patients with type 2 diabetes. Atherosclerosis 206, 569-574.
48. Gammelmark A, Madsen T, Varming K, et al. (2012) Lowdose fish oil supplementation increases serum adiponectin without affecting inflammatory markers in overweight subjects. Nutr Res 32, 15-23.
49. Koh KK, Quon MJ, Shin KC, et al. (2012) Significant differential effects of omega-3 fatty acids and fenofibrate in patients with hypertriglyceridemia. Atherosclerosis 220, 537-544.
50. Mohammadi E, Rafraf M, Farzadi L, et al. (2012) Effects of omega-3 fatty acids supplementation on serum adiponectin levels and some metabolic risk factors in women with polycystic ovary syndrome. Asia Pac J Clin Nutr 21, 511-518.
51. Munro IA & Garg ML (2012) Dietary supplementation with n-3 PUFA does not promote weight loss when combined with a very-low-energy diet. Br J Nutr 108, 1466-1474.
52. Simão ANC, Lozovoy MAB, Bahls LD, et al. (2012) Blood pressure decrease with ingestion of a soya product (kinako) or fish oil in women with the metabolic syndrome: role of adiponectin and nitric oxide. Br J Nutr 108, 1435-1442.
53. Zhang J, Wang C, Li L, et al. (2012) Dietary inclusion of salmon, herring and pompano as oily fish reduces CVD risk markers in dyslipidaemic middle-aged and elderly Chinese women. Br J Nutr 108, 1455-1465.
54. Guebre-Egziabher F, Debard C, Drai J, et al. (2013) Differential dose effect of fish oil on inflammation and adipose tissue gene expression in chronic kidney disease patients. Nutrition 29, 730-736.
55. Spencer M, Finlin BS, Unal R, et al. (2013) Omega-3 fatty acids reduce adipose tissue macrophages in human subjects with insulin resistance. Diabetes 62, 1709-1717.
56. Risérus U, Vessby B, Arner P, et al. (2004) Supplementation with trans10cis12-conjugated linoleic acid induces hyperproinsulinaemia in obese men: close association with impaired insulin sensitivity. Diabetologia 47, 1016-1019.
57. Syvertsen C, Halse J, Hoivik HO, et al. (2007) The effect of 6 months supplementation with conjugated linoleic acid on insulin resistance in overweight and obese. Int J Obes (Lond) 31, 1148-1154.
58. Norris LE, Collene AL, Asp ML, et al. (2009) Comparison of dietary conjugated linoleic acid with safflower oil on body composition in obese postmenopausal women with type 2 diabetes mellitus. Am J Clin Nutr 90, 468-476.
59. Zhao WS, Zhai JJ, Wang YH, et al. (2009) Conjugated linoleic acid supplementation enhances antihypertensive effect of ramipril in Chinese patients with obesity-related hypertension. Am J Hypertens 22, 680-686.
60. MacRedmond R, Singhera G, Attridge S, et al. (2010) Conjugated linoleic acid improves airway hyper-reactivity in overweight mild asthmatics. Clin Exp Allergy 40, 1071-1078.
61. Joseph SV, Jacques H, Plourde M, et al. (2011) Conjugated linoleic acid supplementation for 8 weeks does not affect body composition, lipid profile, or safety biomarkers in overweight, hyperlipidemic men. J Nutr 141, 1286-1291.
62. Nelson TL, Stevens JR & Hickey MS (2007) Adiponectin levels are reduced, independent of polymorphisms in the adiponectin gene, after supplementation with alpha-linolenic acid among healthy adults. Metabolism 56, 1209-1215.
63. Lithander FE, Keogh GF, Wang Y, et al. (2008) No evidence of an effect of alterations in dietary fatty acids on fasting adiponectin over 3 weeks. Obesity (Silver Spring) 16, 592-599.
64. Ratliff JC, Mutungi G, Puglisi MJ, et al. (2008) Eggs modulate the inflammatory response to carbohydrate restricted diets in overweight men. Nutr Metab (Lond) 5, 6.
65. Vega-Lopez S, Matthan NR, Ausman LM, et al. (2009) Substitution of vegetable oil for a partially-hydrogenated fat favorably alters cardiovascular disease risk factors in moderately hypercholesterolemic postmenopausal women. Atherosclerosis 207, 208-212.
66. Kalgaonkar S, Almario RU, Gurusinghe D, et al. (2011) Differential effects of walnuts vs almonds on improving metabolic and endocrine parameters in PCOS. Eur J Clin Nutr 65, 386-393.
67. Aronis KN, Vamvini MT, Chamberland JP, et al. (2012) Shortterm walnut consumption increases circulating total adiponectin and apolipoprotein A concentrations, but does not affect markers of inflammation or vascular injury in obese humans with the metabolic syndrome: data from a doubleblinded, randomized, placebo-controlled study. Metabolism 61, 577-582.
68. Bjermo H, Iggman D, Kullberg J, et al. (2012) Effects of n-6 PUFAs compared with SFAs on liver fat, lipoproteins, and inflammation in abdominal obesity: a randomized controlled trial. Am J Clin Nutr 95, 1003-1012.
69. Manning PJ, Sutherland WH, Williams SM, et al. (2012) The effect of lipoic acid and vitamin E therapy in individuals with metabolic syndrome. Nutr Metab Cardiovasc Dis 23, 543-549.
70. Kontogianni MD, Vlassopoulos A, Gatzieva A, et al. (2013) Flaxseed oil does not affect inflammatory markers and lipid profile compared to olive oil, in young, healthy, normal weight adults. Metabolism 62, 686-693.
71. Somerset SM, Graham L & Markwell K (2013) Isoenergetic replacement of dietary saturated with monounsaturated fat via macadamia nuts enhances endothelial function in overweight subjects. e-SPEN J 8, e113-e119.
72. Banga A, Unal R, Tripathi P, et al. (2009) Adiponectin translation is increased by the PPARg agonists pioglitazone and omega-3 fatty acids. Am J Physiol Endocrinol Metab 296, E480-E489.
73. Bernstein AM, Ding EL, Willett WC, et al. (2012) A metaanalysis shows that docosahexaenoic acid from algal oil reduces serum triglycerides and increases HDL-cholesterol and LDL-cholesterol in persons without coronary heart disease. J Nutr 142, 99-104.
74. Karbowska J & Kochan Z (2006) Role of adiponectin in the regulation of carbohydrate and lipid metabolism. J Physiol Pharmacol 57, Suppl. 6, 103-113.
75. Riserus U, Vessby B, Arnlov J, et al. (2004) Effects of cis-9, trans-11 conjugated linoleic acid supplementation on insulin sensitivity, lipid peroxidation, and proinflammatory markers in obese men. Am J Clin Nutr 80, 279-283.
76. Hollis S & Campbell F (1999) What is meant by intention to treat analysis? Survey of published randomised controlled trials. BMJ 319, 670-674.
77. Moher D, Liberati A, Tetzlaff J, et al. (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement. PLoS Med 6, e1000097.